We are thrilled to announce Biomeme, Inc. has been awarded a Redevelopment Assistance Capital Program (RACP) grant of $3 million from the...

United Kingdom New Variant

Biomeme has confirmed, through in silico analysis of the genetic sequences, that our SARS-CoV-2 assay detects the new...

The finalists have been announced and Biomeme is moving forward to the next round of XPRIZE Rapid COVID Testing, a $6 million dollar 6-month...

When you walk into Biomeme HQ in Philadelphia, you’ll find a bustling office overflowing with our staff, incoming and outgoing packages, and an...

Launched on July 28, 2020, XPRIZE Rapid Covid Testing is a $5 million, 6-month competition that aims to increase Covid-19 testing capabilities...

We all want to make the world a better place, right?

Whether you’re a doctor, public servant, or construction worker, we all play a part in making...

We are pleased to announce that the U.S. Food and Drug Administration (FDA) granted Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use...

“Ahhhh-CHOO!”

Cut to me frantically searching “COVID-19 symptoms” on Google for what must be the millionth time this year.

“Could I have...

With the results of the AMR Challenge quickly approaching, we wanted to take a moment to reflect on our amazing team’s development activities over...

We are proud to announce that Biomeme’s portable test solution to detect SARS-CoV-2 was approved for in vitro diagnostic use by Health Canada on...